Related Experiment Video

Updated: Dec 7, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.2K

Rivaroxaban in COMPASS trial

Filip Šustr, Miroslav Souček

    Vnitrni Lekarstvi
    |September 25, 2020
    PubMed

    Insights

    Secondary prevention of cardiovascular diseases (CVD) is crucial. The COMPASS trial found that combining rivaroxaban with acetylsalicylic acid effectively prevents CVD progression and relapse in patients.

    Area of Science:

    • Cardiology
    • Pharmacology
    • Public Health

    Background:

    • Cardiovascular diseases (CVD) are the leading cause of mortality in Europe.
    • Effective secondary prevention strategies are essential to combat high CVD mortality rates.
    • Antithrombotic treatment is considered the gold standard for secondary CVD prevention.

    Purpose of the Study:

    • To evaluate the effectiveness of rivaroxaban in secondary prevention of CVD.
    • To assess the combined efficacy of rivaroxaban and acetylsalicylic acid in CVD patients.

    Main Methods:

    • The study focused on the COMPASS trial.
    • Investigated the use of rivaroxaban as a secondary prevention therapy for CVD.
    • Analyzed patient outcomes related to disease progression and relapse.

    Main Results:

    • The COMPASS trial demonstrated positive outcomes for rivaroxaban use in CVD secondary prevention.
    • Combining rivaroxaban with acetylsalicylic acid showed significant benefits.
    • This combination therapy aids in preventing the progression or relapse of cardiovascular diseases.

    Conclusions:

    • Rivaroxaban, particularly in combination with acetylsalicylic acid, is a highly effective option for secondary CVD prevention.
    • This therapeutic approach offers a promising strategy to reduce CVD-related mortality and morbidity.

    Keywords:
    ASACOMPASScoronary artery diseaserivaroxaban

    More Related Videos

    A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis10:26

    A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

    Published on: June 2, 2015

    17.7K
    Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation06:04

    Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

    Published on: August 8, 2025

    420

    Related Concept Videos

    Compass01:23

    Compass

    The compass is a fundamental instrument that operates by aligning its magnetic needle with Earth's magnetic field. This alignment facilitates navigation and orientation, offering a means to determine direction relative to magnetic north. However, the magnetic needle points to magnetic north, which differs slightly from true geographic north due to magnetic declination, which is the angular deviation between these two points. Declination varies based on geographic location and shifts over time...
    3.1K
    Clinical Trials01:16

    Clinical Trials

    Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
    There are four phases in a clinical trial. A phase one...
    10.0K
    Clinical Trials: Overview01:11

    Clinical Trials: Overview

    Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
    4.4K
    Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

    Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

    Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
    Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
    1.7K
    Pharmacovigilance01:19

    Pharmacovigilance

    Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
    This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
    In some cases, there...
    1.5K
    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
    1.3K